The U.S. Department of Justice says False Claims Act lawsuits recovered $4.7 billion in fiscal 2016, more than the $3.6 billion recovered in fiscal 2015, and the third-largest annual tally in the FCA’s history.
Insys had just one product, Subsys, a spray version of one of the most addictive narcotics on earth, and they had just one business plan -- bribe doctors to prescribe it, and ever mind that the drug was only FDA-approved for cancer patients in need of continuous pain medication.
The editor of Corporate Crime Reporter called us up.
What did we think of Sen. Jeff Sessions (R-AL), President-elect Donald Trump's pick for Attorney General? Our reply:
Freeing the False Claims Act
Joyce Branda was given the TAF Education Fund's Lifetime Achievement Award in honor of her 30-years of leadership in helping recover more than $50 billion back to the federal government through the use of the federal False Claims Act. Ms. Branda has been a model public servant working to reconcile diverse, competing, and sometimes conflicting, voices and interests. Through it all, she has been a steward of America’s tax dollars and of the False Claims Act itself. The TAF Education Fund's Lifetime Achievement Award has only been given out six times in the past, and Ms. Branda is the first government recipient.
Public Citizen has updated its 3-year old report on pharmaceutical industry fraud, and one conclusion of the report is that there has been a short-term drop in financial penalties levied against the fraudsters.
While total False Claims Act (whistleblower and non-whistleblower) recoveries were down from their record in FY 2014, a higher percentage of successful cases were filed by whistleblowers in 2015, and a very high percentage of these successful cases were initiated by whistleblowers, and declined by the U.S. Department of Justice.
A new report by the Government Accountability Office finds widespread problems with the IRS Whistleblower Program. Despite collecting an additional $2 billion in revenue since 2011, the IRS whistleblower program is marked by procedural delays, whistleblower payment issues, and communication failures to stakeholders.
- 1 of 3
- next ›